Louis J. Arcudi III currently serves as Amolyt Pharma’s Chief Financial Officer. Louis joined Amolyt from Millendo Therapeutics, where he served as Chief Executive Officer since February 2021, and Chief Financial Officer prior to that. Prior to joining Millendo, he served as Senior Vice President of Operations and Chief Financial Officer at Idera Pharmaceuticals. Before that, Louis served as Vice President of Finance and Administration for Peptimmune, Inc. where he handled all financial business and operations. Before his time at Peptimmune, he served as Senior Director of Finance and Administration at Genzyme Molecular Oncology Corporation, after serving as Director of International Finance and Commercial Operations at Genzyme Corporation. Earlier in his career, he held finance positions with increasing levels of responsibility at Cognex Corporation, Millipore Corporation and General Motors Corporation. Louis obtained his MBA from Bryant College and B.S. in Accounting and Information Systems from the University of Southern New Hampshire.